Understanding the Experience of Healthcare Access and Health-Related Impacts among Individuals with Alopecia Areata

Main Article Content

Candrice R. Heath
Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania; Howard University, Department of Dermatology, Washington, DC; Center for Urban Bioethics, Temple University, Philadelphia, Pennsylvania

Lisa Anderson
National Alopecia Areata Foundation, San Rafael, California

Shamsha Damani
National Alopecia Areata Foundation, San Rafael, California

Elizabeth D. Bacci
Patient-Centered Research, Evidera, Wilmington, North Carolina

Andrew Buchanan
Eli Lilly and Company, Indianapolis, Indiana

Julia R. Correll
Patient-Centered Research, Evidera, Wilmington, North Carolina

Evangeline J. Pierce
Eli Lilly and Company, Indianapolis, Indiana

Melissa L. Constantine
Patient-Centered Research, Evidera, Wilmington, North Carolina

Beth Mitchell
Eli Lilly and Company, Indianapolis, Indiana

Raj Chovatiya
Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois; Center for Medical Dermatology + Immunology, Chicago, Illinois

Keywords

Alopecia Areata

Abstract

n/a

References

1. Gelhorn HL, et al. Dermatol Ther. 2022;12(4):989-997.

2. Mesinkovska N, et al. J Investig Dermatol Symp Proc. 2020;20(1):S62-S68

Article Sidebar

PDF
Published
Jan 13, 2025
DOI https://doi.org/10.25251/skin.9.supp.523

Article Details

How to Cite
[1]
Heath, C., Anderson, L., Damani, S., Bacci, E., Buchanan, A., Correll, J., Pierce, E., Constantine, M., Mitchell, B. and Chovatiya, R. 2025. Understanding the Experience of Healthcare Access and Health-Related Impacts among Individuals with Alopecia Areata . SKIN The Journal of Cutaneous Medicine. 9, 1 (Jan. 2025), s523. DOI:https://doi.org/10.25251/skin.9.supp.523.
Issue
Vol. 9 No. 1 (2025): January 2025 Issue
Section
Alopecia
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Most read articles by the same author(s)

1 2 3 4 > >>